Fresenius sent a letter to customers in November warning them about the problem. The FDA classified the recall a month later as Class I, its highest risk category, according to an enforcement report.

Add Yahoo as a preferred source to see more of our stories on Google. Fresenius Kabi recalled some of its large volume infusion pumps over a software problem that can lead to delays or interruptions ...

From left to right: Ms. Jacq Chua, representing Magna Dos Merchants, Inc.; Ms. Sabrina O. Tan, Chief Financial Officer, Magna Prime Chemical Technologies, Inc.; Inv ...